11.05.2016 - Pfizer has entered into an agreement with Wave Life Sciences to develop and commercialize nucleic acid therapies for metabolic diseases. The collaboration, potentially worth more...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)